questionsmedicales.fr
Acides nucléiques, nucléotides et nucléosides
Nucléotides
Ribonucléotides
Nucléoside diphosphate ose
Adénosine diphosphate ose
Adénosine diphosphate ribose
O-acétyl-ADP-ribose
O-acétyl-ADP-ribose : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Analyse Chromatographique
Spectrométrie de Masse
Tests Biochimiques
Dosage Enzymatique
Échantillons Sanguins
Méthodes de Mesure
Biomarqueurs
Niveaux Biologiques
Dysfonctionnement Cellulaire
Troubles Métaboliques
Symptômes
5
Douleur
Troubles Inflammatoires
Troubles Neurologiques
Études Cliniques
Symptômes Digestifs
Déséquilibres Métaboliques
Système Immunitaire
Réponse Immunitaire
Prévention
5
Mode de Vie Sain
Prévention des Maladies
Exercice Physique
Métabolisme
Suppléments
Consultation Médicale
Traitements
5
Inhibiteurs Enzymatiques
Modulateurs Métaboliques
Médicaments
Voies Métaboliques
Thérapies Alternatives
Suppléments Nutritionnels
Alimentation Équilibrée
Régulation Métabolique
Interventions Chirurgicales
Complications Médicales
Complications
5
Complications Métaboliques
Inflammation
Maladies Chroniques
Diabète
Troubles Cardiovasculaires
Études Épidémiologiques
Santé Mentale
Troubles Associés
Infections
Système Immunitaire
Facteurs de risque
5
Facteurs de Risque
Mode de Vie
Vieillissement
Santé Cellulaire
Mode de Vie Sédentaire
Déséquilibres Métaboliques
Maladies Préexistantes
Diabète
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "O-acétyl-ADP-ribose : Questions médicales les plus fréquentes",
"headline": "O-acétyl-ADP-ribose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les O-acétyl-ADP-ribose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-08",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "O-acétyl-ADP-ribose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Adénosine diphosphate ribose",
"url": "https://questionsmedicales.fr/mesh/D000246",
"about": {
"@type": "MedicalCondition",
"name": "Adénosine diphosphate ribose",
"code": {
"@type": "MedicalCode",
"code": "D000246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.695.827.708.070.125"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "O-acétyl-ADP-ribose",
"alternateName": "O-Acetyl-ADP-Ribose",
"code": {
"@type": "MedicalCode",
"code": "D038961",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anthony K L Leung",
"url": "https://questionsmedicales.fr/author/Anthony%20K%20L%20Leung",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA."
}
},
{
"@type": "Person",
"name": "Morgan Dasovich",
"url": "https://questionsmedicales.fr/author/Morgan%20Dasovich",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA."
}
},
{
"@type": "Person",
"name": "Mohsen Badiee",
"url": "https://questionsmedicales.fr/author/Mohsen%20Badiee",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205."
}
},
{
"@type": "Person",
"name": "Yong Zhang",
"url": "https://questionsmedicales.fr/author/Yong%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California 90089, United States."
}
},
{
"@type": "Person",
"name": "Sua Myong",
"url": "https://questionsmedicales.fr/author/Sua%20Myong",
"affiliation": {
"@type": "Organization",
"name": "Program in Cell, Molecular, Developmental Biology, and Biophysics, Johns Hopkins University, Baltimore, Maryland 21218, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Endometrial cancer after endometrial ablation: a systematic review.",
"datePublished": "2022-12-05",
"url": "https://questionsmedicales.fr/article/36375895",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ijgc-2022-003866"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endometrial carcinosarcoma.",
"datePublished": "2023-02-06",
"url": "https://questionsmedicales.fr/article/36585027",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ijgc-2022-004073"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endometrial Hyperplasia.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36357974",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/AOG.0000000000004989"
}
},
{
"@type": "ScholarlyArticle",
"name": "The relationship between endometrial thickening and endometrial lesions in postmenopausal women.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36006486",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-022-06734-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid.",
"datePublished": "2023-05-12",
"url": "https://questionsmedicales.fr/article/37240034",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24108683"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Nucléotides",
"item": "https://questionsmedicales.fr/mesh/D009711"
},
{
"@type": "ListItem",
"position": 4,
"name": "Ribonucléotides",
"item": "https://questionsmedicales.fr/mesh/D012265"
},
{
"@type": "ListItem",
"position": 5,
"name": "Nucléoside diphosphate ose",
"item": "https://questionsmedicales.fr/mesh/D009702"
},
{
"@type": "ListItem",
"position": 6,
"name": "Adénosine diphosphate ose",
"item": "https://questionsmedicales.fr/mesh/D000247"
},
{
"@type": "ListItem",
"position": 7,
"name": "Adénosine diphosphate ribose",
"item": "https://questionsmedicales.fr/mesh/D000246"
},
{
"@type": "ListItem",
"position": 8,
"name": "O-acétyl-ADP-ribose",
"item": "https://questionsmedicales.fr/mesh/D038961"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : O-acétyl-ADP-ribose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur O-acétyl-ADP-ribose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur O-acétyl-ADP-ribose",
"description": "Comment détecter l'O-acétyl-ADP-ribose dans les cellules ?\nQuels tests sont utilisés pour évaluer l'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose est-il mesurable dans le sang ?\nY a-t-il des biomarqueurs associés à l'O-acétyl-ADP-ribose ?\nQuels sont les indicateurs de dysfonctionnement de l'O-acétyl-ADP-ribose ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Endometrial+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur O-acétyl-ADP-ribose",
"description": "Quels symptômes sont liés à des niveaux anormaux d'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose provoque-t-il des douleurs ?\nY a-t-il des symptômes neurologiques liés à l'O-acétyl-ADP-ribose ?\nDes symptômes digestifs peuvent-ils être liés à l'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose affecte-t-il le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Endometrial+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur O-acétyl-ADP-ribose",
"description": "Comment prévenir les déséquilibres d'O-acétyl-ADP-ribose ?\nY a-t-il des recommandations diététiques pour l'O-acétyl-ADP-ribose ?\nL'exercice physique aide-t-il à réguler l'O-acétyl-ADP-ribose ?\nLe stress influence-t-il l'O-acétyl-ADP-ribose ?\nDes suppléments peuvent-ils prévenir les déséquilibres d'O-acétyl-ADP-ribose ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Endometrial+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur O-acétyl-ADP-ribose",
"description": "Quels traitements ciblent l'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose peut-il être traité par des médicaments ?\nY a-t-il des thérapies alternatives pour l'O-acétyl-ADP-ribose ?\nComment l'alimentation influence-t-elle l'O-acétyl-ADP-ribose ?\nDes interventions chirurgicales sont-elles nécessaires pour l'O-acétyl-ADP-ribose ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Endometrial+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur O-acétyl-ADP-ribose",
"description": "Quelles complications peuvent survenir avec l'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose est-il lié à des maladies chroniques ?\nDes troubles cardiovasculaires peuvent-ils être liés à l'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose peut-il affecter la santé mentale ?\nY a-t-il des risques d'infection liés à l'O-acétyl-ADP-ribose ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Endometrial+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur O-acétyl-ADP-ribose",
"description": "Quels facteurs de risque influencent l'O-acétyl-ADP-ribose ?\nL'âge est-il un facteur de risque pour l'O-acétyl-ADP-ribose ?\nLe tabagisme influence-t-il l'O-acétyl-ADP-ribose ?\nLe manque d'exercice est-il un facteur de risque ?\nDes maladies préexistantes augmentent-elles le risque d'O-acétyl-ADP-ribose ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Endometrial+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecter l'O-acétyl-ADP-ribose dans les cellules ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la chromatographie et la spectrométrie de masse sont utilisées."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'O-acétyl-ADP-ribose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests biochimiques et les dosages enzymatiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose est-il mesurable dans le sang ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être mesuré dans des échantillons sanguins par des méthodes spécifiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés à l'O-acétyl-ADP-ribose ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des biomarqueurs spécifiques peuvent indiquer des niveaux d'O-acétyl-ADP-ribose."
}
},
{
"@type": "Question",
"name": "Quels sont les indicateurs de dysfonctionnement de l'O-acétyl-ADP-ribose ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux peuvent indiquer des troubles métaboliques ou cellulaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à des niveaux anormaux d'O-acétyl-ADP-ribose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés peuvent inclure fatigue, troubles métaboliques et inflammation."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose provoque-t-il des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut être associé à des douleurs dues à des troubles métaboliques ou inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques liés à l'O-acétyl-ADP-ribose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel avec des troubles neurologiques, mais c'est encore à explorer."
}
},
{
"@type": "Question",
"name": "Des symptômes digestifs peuvent-ils être liés à l'O-acétyl-ADP-ribose ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres métaboliques peuvent entraîner des symptômes digestifs."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose affecte-t-il le système immunitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut influencer la réponse immunitaire, entraînant des symptômes d'inflammation."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déséquilibres d'O-acétyl-ADP-ribose ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain et équilibré peut aider à prévenir ces déséquilibres."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations diététiques pour l'O-acétyl-ADP-ribose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants et nutriments peut soutenir la santé cellulaire."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à réguler l'O-acétyl-ADP-ribose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer le métabolisme et réguler les niveaux d'O-acétyl-ADP-ribose."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il l'O-acétyl-ADP-ribose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut perturber les niveaux d'O-acétyl-ADP-ribose et affecter la santé."
}
},
{
"@type": "Question",
"name": "Des suppléments peuvent-ils prévenir les déséquilibres d'O-acétyl-ADP-ribose ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments peuvent aider, mais il est essentiel de consulter un professionnel de santé."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent l'O-acétyl-ADP-ribose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs enzymatiques et des modulateurs métaboliques sont explorés comme traitements."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose peut-il être traité par des médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours pour développer des médicaments ciblant ses voies métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies alternatives pour l'O-acétyl-ADP-ribose ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies alternatives, comme les suppléments, sont étudiées mais nécessitent plus de preuves."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle l'O-acétyl-ADP-ribose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut aider à réguler les niveaux d'O-acétyl-ADP-ribose."
}
},
{
"@type": "Question",
"name": "Des interventions chirurgicales sont-elles nécessaires pour l'O-acétyl-ADP-ribose ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, les interventions chirurgicales ne sont pas nécessaires, sauf en cas de complications graves."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'O-acétyl-ADP-ribose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications métaboliques et inflammatoires peuvent survenir en cas de déséquilibre."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose est-il lié à des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux peuvent être associés à des maladies chroniques comme le diabète."
}
},
{
"@type": "Question",
"name": "Des troubles cardiovasculaires peuvent-ils être liés à l'O-acétyl-ADP-ribose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel entre les déséquilibres et les troubles cardiovasculaires."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose peut-il affecter la santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches indiquent qu'il pourrait influencer la santé mentale et les troubles associés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques d'infection liés à l'O-acétyl-ADP-ribose ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des déséquilibres peuvent affaiblir le système immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent l'O-acétyl-ADP-ribose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'alimentation, le stress et le mode de vie peuvent influencer ses niveaux."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour l'O-acétyl-ADP-ribose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter les niveaux d'O-acétyl-ADP-ribose et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'O-acétyl-ADP-ribose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut perturber le métabolisme et affecter les niveaux d'O-acétyl-ADP-ribose."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut contribuer à des déséquilibres d'O-acétyl-ADP-ribose."
}
},
{
"@type": "Question",
"name": "Des maladies préexistantes augmentent-elles le risque d'O-acétyl-ADP-ribose ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies, comme le diabète, peuvent augmenter le risque de déséquilibres."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/03/2025
Contenu vérifié selon les dernières recommandations médicales
10 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
5 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Department of Chemistry, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD 21218, USA.
Publications dans "O-acétyl-ADP-ribose" :
5 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205.
Publications dans "O-acétyl-ADP-ribose" :
4 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California 90089, United States.
Department of Chemistry, Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California 90089, United States.
Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089, United States.
Research Center for Liver Diseases, University of Southern California, Los Angeles, California 90089, United States.
Publications dans "O-acétyl-ADP-ribose" :
4 publications dans cette catégorie
Affiliations :
Program in Cell, Molecular, Developmental Biology, and Biophysics, Johns Hopkins University, Baltimore, Maryland 21218, United States.
Department of Biophysics, Johns Hopkins University, Baltimore, Maryland 21218, United States.
Physics Frontier Center (Center for the Physics of Living Cells), University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Department of Biomedical Sciences, Chung Shan Medical University, Taichung, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Department of Food Science and Biotechnology, Da-Yeh University, Changhua, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Department of Food Science and Biotechnology, Da-Yeh University, Changhua, Taiwan.
Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
Guang EM Laboratory, New Taipei, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Section of Laboratory Research, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: Cristel.Camacho@utsouthwestern.edu.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Department of Neuroscience, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Department of Neuroscience, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Publications dans "O-acétyl-ADP-ribose" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
2 publications dans cette catégorie
Affiliations :
Molecular Toxicology Group, University of Konstanz, Konstanz, Germany.
Publications dans "O-acétyl-ADP-ribose" :
To investigate whether a previously performed endometrial ablation is associated with the development and diagnosis of endometrial cancer....
First, a systematic review was performed of the articles reporting the incidence of endometrial cancer in patients treated with endometrial ablation. Second, a systematic review was performed to ident...
Based on 11 included studies, the incidence of endometrial cancer in a population of 29 102 patients with a prior endometrial ablation ranged from 0.0% to 1.6%.A total of 38 cases of endometrial cance...
Previous endometrial ablation is not associated with the development of endometrial cancer. Diagnostic work-up is not impeded by previous endometrial ablation. In addition, endometrial cancers after e...
Endometrial carcinosarcoma is a rare and aggressive high-grade endometrial carcinoma with secondary sarcomatous trans-differentiation (conversion theory). The clinical presentation and diagnostic work...
The objectives of this Clinical Expert Series on endometrial hyperplasia are to review the etiology and risk factors, histologic classification and subtypes, malignant progression risks, prevention op...
The study aims to investigate the relationship between endometrial thickening and endometrial lesions in postmenopausal women....
Totally 390 postmenopausal patients with endometrial thickening ≥ 5 mm were enrolled from June 2016 to April 2020, among whom 188 patients were asymptomatic and 202 patients were symptomatic....
There were 50 cases with endometrial cancer and precancerous lesions and 150 cases with benign lesions in the symptomatic group, significantly higher than that in the asymptomatic group. The most comm...
The incidence of endometrial cancer and precancerous lesions in postmenopausal women with endometrial thickening and vaginal bleeding is higher than that of asymptomatic women. The endometrial thicken...
Abnormal uterine bleeding is a common benign gynecological complaint and is also the most common symptom of endometrial cancer (EC). Although many microRNAs have been reported in endometrial carcinoma...
The risk of developing endometrial hyperplasia after diagnosis of endometriosis has not been determined. Moreover, the risk of endometrial cancer associated with endometriosis is unclear. This nationw...
This population-based observational study analyzed data from the Korean National Health Insurance (NHI) database, including 147,869 women who were diagnosed with endometriosis from 2002 to 2017, with ...
Among three million women in this population, 16,377 women were diagnosed with endometrial hyperplasia, and 1795 women were diagnosed with endometrial cancer over 19,931,794 person-years of follow-up....
The risks of endometrial hyperplasia and endometrial cancer were found to be significantly higher in women with than without endometriosis. The presence of endometriosis did not affect overall surviva...
To investigate the factors related to endometrial cancer (EC) in postmenopausal women with endometrial thickening and the value of endometrial thickness (ET) in predicting EC....
A retrospective study of 385 referrals to our department for hysteroscopic diagnostic curettage assessment was carried out. Univariate analysis and multiple logistic regression analysis were used to i...
The follow-up period from the identification of endometrial thickening to pathological confirmation of EC was from 2 weeks to 3 months. In the postmenopausal bleeding (PMB) group, a total of 47 partic...
For postmenopausal women with increased ET and PMB, older age, thicker ET, and polypoid mass-like lesions on transvaginal ultrasound were independent associated factors for EC. An ET greater than 9.5 ...
Endometrial cancer is the most common gynecologic cancer in the United States and Europe, with an increasing incidence rate in high-income countries. MR imaging is recommended for treatment planning b...
The Cancer Genome Atlas (TCGA) endometrial cancer data expanded our knowledge about the role of different immunotherapeutic approaches based on molecular subtypes. Immune checkpoint inhibitors demonst...
To evaluate whether the amount of preoperative endometrial tissue surface is related to the degree of concordance with final low- and high-grade endometrial cancer (EC). In addition, to determine whet...
A retrospective cohort study within the European Network for Individualized Treatment of Endometrial Cancer (ENITEC). Surface of preoperative endometrial tissue samples was digitally calculated using ...
The study cohort included 573 tumor samples. Overall concordance between pre- and postoperative diagnosis was 60.0%, and 88.8% when classified into low- and high-grade EC. Upgrading (preoperative low-...
The amount of preoperative endometrial tissue surface was inversely related to the degree of concordance with final tumor low- and high-grade. Obtaining higher amount of preoperative endometrial tissu...